CTCs

Dec 9, 2021

Rarecells Raises $13M in Series A Round to Develop Liquid Biopsy Early Cancer Detection Tests

Aug 18, 2021

Datar Cancer Genetics Expands Business from Treatment Monitoring to Dx and Screening
Premium

Jul 21, 2021

Biocept HER2 Assay Gains Coverage Under Medicare Local Coverage Determination for CTC Tests

May 10, 2021

TellBio Raises $5M in Series A Round, Inks Deals With Genetron, ARUP for Liquid Biopsy Platform

Mar 31, 2021

Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay
Premium

Mar 29, 2021

Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag

Mar 24, 2021

Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform

Mar 23, 2021

CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test

Mar 18, 2021

Scienion, Gilupi to Develop Circulating Tumor Cell Analysis Workflow

Jan 21, 2021

OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay
Premium

Nov 19, 2020

Epic Sciences, USC Michelson Center Sign Licensing Agreement for Liquid Biopsy Research

Nov 13, 2020

Biocept Eyes Neuro-Oncology for Future Liquid Biopsy Growth as Testing Lags Amid COVID Pandemic

Nov 9, 2020

Savran Technologies to Target Breast Cancer Recurrence with Circulating Tumor Cell Platform

Sep 28, 2020

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

Jul 10, 2020

Presence of cfDNA, CTCs Predicts Recurrence in Triple-Negative Breast Cancer

Jun 29, 2020

Creatv MicroTech Aims to Detect Patient Immune Cells for Cancer Drug Response Prediction

May 13, 2020

Biocept Q1 Revenues Up 41 Percent

May 7, 2020

Prospective Study Adds Evidence for CellMax Life Liquid Biopsy Utility in CRC Screening

Mar 16, 2020

Biolidics Raising SGD $3.1M Through Share Placements

Jan 14, 2020

Celsee, Kindstar Ink Chinese Distribution Deal for Single-Cell Isolation Platform